Story cites systematic review of research led by Shelley Selph, M.D., M.P.H., revealing that behavioral health interventions in primary care have a moderate net benefit in preventing tobacco use among children.

Story highlights new research showing increased susceptibility to health hazards, including COVID-19, among African Americans and Latinos living in areas of poor air quality. Lynne Messer, Ph.D., M.P.H., says, “Anything that’s going to undermine respiratory health, like air pollution, is going to put people at increased risk for mortality from a virus that’s going to attack people’s lungs.”

In a story about blood testing for coronavirus antibodies, Mark Slifka, Ph.D., says, “It’s very hard to protect the nose from being reinfected.”

Story reveals underlying conditions associated with many COVID-19 deaths in Oregon, including heart disease and immune disorders. Dawn Nolt, M.D., says this isn’t surprising: “You are probably going to have a harder time combating the infection and in fact may have more serious consequences.”

Curtis Thompson, M.D., is quoted in a story about foot rashes documented in some cases of COVID-19, similar to the body’s immune response to lupus. He says, “You could take these biopsies and put them in a textbook under the lupus chapter.”

A staff editorial in The Register-Guard (Eugene) cites observation by Renee Edwards, M.D., that an overall easing of restrictions will increase the number of people who get sick.

Renee Edwards, M.D., is quoted in a story about her participation in a medical advisory panel for Gov. Kate Brown. She says, “Her team listens, collates our thoughts, clarifies things but ultimate authority absolutely is with the governor.”

A profile documents the story of the company’s “race to deliver protective equipment into the hands of healthcare workers fighting to save lives, as told by those who came together to make it possible.”

John Townes, M.D., and David Bangsberg, M.D., M.P.H., are quoted in a story about a higher-than-expected number of deaths in Oregon this year. Bangsberg says, “There probably is a real bump in excess mortality, related to COVID-19.”

In a story about a trial examining famotidine as a potential COVID-19 treatment, Jim Lewis, Pharm.D., says "We can’t reiterate strong enough to absolutely not take this drug without talking to your health care provider first.”